BIOMARKERS

With the emergence of personalized medicine and the ability to predict medical diagnosis/prognosis based on a patient’s genetic makeup, more and more researchers have begun to incorporate biomarker analysis into their research.

Building

Genomics in Biomarkers



Basic scientists identify and analyze molecular biomarkers in their pathways of interest to get a clearer understanding of these pathways and the resulting physiology or pathology.
Drug developers incorporate biomarker discovery into their R&D, pre-clinical, and clinical workflows to develop targeted therapies which will result in better efficacy. Some biomarkers that have resulted in effective targeted drugs include BRAF, HER2, EGFR, and KRAS to name a few. Biomarkers have recently taken on added significance in cancer diagnosis and treatment but also play an important role in various other therapeutic areas.
In medicine, healthcare practitioners rely on pharmacogenomics testing to analyze a patient’s genomic profile in order to accurately prescribe the most effective medications with as few side-effects as possible.

Applications


GENEWIZ offers a number of genomics solutions to assist in biomarker research and discovery.


  • Building

    RNA-Seq

    The throughput of RNA-Seq allows researchers to analyze the entire transcriptome of an organism and thereby discover molecular biomarkers related to gene expression, alternative transcripts or splicing events.


    Learn More





  • Building

    Whole Genome Sequencing

    Full-service whole genome sequencing allows the comprehensive analysis of entire genomes to reveal implicated genotypes or discover previously unknown SNPs, genes, or other biomarkers.


    Learn More




  • Building

    Gene Synthesis

    Advance your proteomic biomarker studies by using our gene synthesis services to quickly obtain your gene of interest.


    Learn More

  • Building

    Bioinformatics Solutions

    Advanced bioinformatics solutions are available to help analyze complex data sets to identify potential biomarkers quickly and efficiently.


    Learn More